© 2006 The Royal College of Psychiatrists
Correspondence |
Abstinence-oriented treatment for opiate addiction
Specialist Community Addictions Service, Rectory Centre, Rectory Road, Oxford OX4 1BU, UK.
Specialist Community Addictions Service, Oxford, UK
Correspondence: E-mail: gail.critchlow{at}oxmhc-tr.nhs.uk
Smyth et al (2005) reported outcomes of abstinence-oriented in-patient treatment for opiate users at 2–3 years and found that 23% of patients were abstinent for the preceding 30 days according to self-report without methadone maintenance. At the start of the treatment 49% had injected heroin. There was, however, a group of patients who were truly abstinent: those who had died.
Of the 109 patients who had been located out of the original 149, 5 had died. The total expected number of deaths from the original sample would therefore be closer to 7, but would perhaps be even higher if we assume that those lost to follow-up led more ‘chaotic’ lifestyles. The authors rightly note that abstinence-oriented treatment is associated with accidental overdose (Strang et al, 2003).
In Glasgow, before the advent of supervised consumption, rates of methadone-related overdose were around 2.5 per 100 treatment-years. This rate fell to less than 0.5 per 100 treatment-years (Advisory Committee on the Misuse of Drugs, 2000) after the supervised consumption of methadone was introduced. Supervised methadone consumption is known to be effective in reducing the risk of overdose and there is a dose-related effect in reducing mortality, with doses over 75 mg being more effective than doses below 55 mg (van Ameijden et al, 1999). Methadone also reduces the risk of injecting; this in turn reduces viral transmission, which is the other significant risk of increased mortality among drug users (Dolan et al, 1998).
However, the attitude of treatment agencies towards extended maintenance is changing in the direction of delineated treatment episodes (National Treatment Agency for Substance Misuse, 2005). In these days of crack cocaine, the belief that methadone treatment works (Gossop et al, 2003) and saves money (Godfrey et al, 2004) has diminished. This is despite evidence for interventions such as contingency management and cognitive–behavioural therapy using substitute prescribing (Rowan-Szal et al, 2004).
Of course, abstinence should be a potential goal of drug treatment. Deciding those patients for whom abstinence-oriented treatment is appropriate, and the risk of such treatment, is more difficult. There is no reliable evidence for matching patients to optimal treatments in addiction. However, those who inject, isolated users and alcohol/benzodiazepine co-users are all over-represented in the morgue (Warner-Smith et al, 2001). Risk awareness might well be a reasonable first step and for many abstinence might be more dangerous than desirable.
REFERENCES
- Advisory Committee on the Misuse of Drugs (2000) Reducing Drug Related Deaths. London: Stationery Office.[CrossRef][Medline]
- Dolan, K., Wodak, A. D. & Hall, W. D. (1998) Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug and Alcohol Review, 17, 153 –158.[CrossRef][Medline]
- Gossop, M., Marsden, J., Stewart, D., et al (2003) The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction, 98, 291 –303.[CrossRef][Medline]
- Godfrey, C., Stewart, D. & Gossop, M. (2004) Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction, 99, 697 –707.[CrossRef][Medline]
- National Treatment Agency for Substance Misuse (2005) Business Plan 2005/6. Towards Treatment Effectiveness. London: NTA. http://www.nta.nhs.uk/publications/Businessplan05.pdf
- Rowan-Szal, G. A., Bartholomew, N. G., Chatham, L. R., et al (2004) A combined cognitive and behavioural intervention for cocaine-using methadone clients. Journal of Psychoactive Drugs, 37, 75 –84.
- Smyth, B. P., Barry, J., Lane, A., et al
(2005) Inpatient treatment of opiate dependence: medium-term
follow-up outcomes. British Journal of Psychiatry,
187, 360
–365.
[Abstract/Free Full Text] - Strang, J., McCambridge, J., Best, D., et al
(2003) Loss of tolerance and overdose mortality after
inpatient opiate detoxification: detoxification: follow up study.
BMJ, 326, 959
–960.
[Free Full Text] - van Ameijden, E. J., Langendam, M.W. & Coutinho, R. A. (1999) Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addictive Behaviors, 24, 559 –563.[CrossRef][Medline]
- Warner-Smith, M., Darke, S., Lynskey, M., et al (2001) Heroin overdose: causes and consequences. Addiction, 96, 1113 –1125.[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||